About Unitron Medx
Unitron Medx is a private limited company (BV/SRL) based in Gent, founded in 2011. Its main activity is classified as "Vervaardiging van elektronische onderdelen". For the 2025 financial year, Unitron Medx reported a loss of €3,587. That makes 4 loss-making financial years in a row for Unitron Medx. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €132,557, up 32% on 2024. It employed an average of 1 full-time equivalent. Equity stands at €7,453, a solvency ratio of 6.4%. In 2012 it was €16,835. 14 annual accounts are available, covering 2012 to 2025.
- Sectors
- Wholesalers
- Signals
-
Reporting lossesReporting losses € -4K
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -3KOperating cash flow was negative in the latest financial year.
Good liquidityGood liquidity 1.96A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive EBITDAPositive EBITDA € 3KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 11.8%Social debts stay manageable relative to personnel costs.
- Directors
- Unitron Holding Bv, Adriaan François Theodoor Hamelink
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
133K
|
€
101K
|
€
2K
|
€
535
|
|
|
€
3K
|
€
-2K
|
€
1K
|
€
15
|
|
|
€
-4K
|
€
-7K
|
€
-949
|
€
-419
|
|
|
€
7K
|
€
11K
|
€
18K
|
€
19K
|
|
|
6.44%
|
5.88%
|
24.91%
|
27.29%
|
|
|
€
108K
|
€
177K
|
€
56K
|
€
52K
|
|
|
€
81K
|
€
10K
|
€
46K
|
€
68K
|
|
|
1
|
1
|
|
|
Publications 10
All publications- Maatschappelijke Zetel 07/10/2025
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Benaming - Diversen - Maatschappelijke Zetel - Doel - Ontslagen - Benoemingen 04/07/2024
- Ontslagen - Benoemingen 28/06/2022
- Maatschappelijke Zetel 17/04/2018
- Me. - Jaarrekening 31.12.2015, Ggk 12.05.2016, Ngl 29.08.2016 16505-0486-009 02/09/2016
Frequently asked questions
Answers to the most common questions about Unitron Medx, based on official government data and the filed annual accounts.
What is the VAT number of Unitron Medx?
The VAT number of Unitron Medx is BE0835.668.559.
How many employees work at Unitron Medx?
In 2025, Unitron Medx employed 1.00 full-time equivalents (FTE).
When was Unitron Medx established?
Unitron Medx was founded in 31-03-2011.
What is the official address of Unitron Medx?
The official address of Unitron Medx is Poortakkerstraat 35B Gent 9051.
What is the legal form of Unitron Medx?
The juridical form of Unitron Medx is Private limited company (BV/SRL).
What is the annual revenue of Unitron Medx?
The 2025 accounts of Unitron Medx do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Unitron Medx a reliable company?
Unitron Medx is a registered Rechtspersoon with company number 0835.668.559 and can be verified through the official CBE database.
What is the credit limit of Unitron Medx?
The estimated credit limit of Unitron Medx is €2,618.
Is Unitron Medx still active?
Unitron Medx currently has the status "Normal situation" and is active.
More companies in Gent
Show all- SP S&H Pharma BV · since 2011
- VV Vastgoed Vano BVBA · since 2011
- V& V & N Comm.V · since 2011
- SM Soul Media BV · since 2011
- DL Dr. Liesbeth De Groote - Neurologe BV · since 2011
- P Pheidias BV · since 2011